Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

● The company has solid fundamentals for a short-term investment strategy.


Strengths

● The stock, which is currently worth 2021 to 0.89 times its sales, is clearly overvalued in comparison with peers.

● Its low valuation, with P/E ratio at 12.16 and 11.9 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● For the past twelve months, EPS forecast has been revised upwards.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The stock is in a well-established, long-term rising trend above the technical support level at 4.51 HKD


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at HKD 10.86.

● The stock is close to a major daily resistance at HKD 11.18, which should be gotten rid of so as to gain new appreciation potential.

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The company is not the most generous with respect to shareholders' compensation.